Patient Engagement in R&D: Still a Challenge for Pharma Companies
DUBLIN–(BUSINESS WIRE)–The “Patient Engagement in R&D: Still a Challenge” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical industry has…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Patient Engagement in R&D: Still a Challenge” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical industry has…
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. The biopharmaceuticals market is driven…
CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced today that multiple abstracts featuring the INTERCEPT Blood System pathogen reduction technology, including four…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Eric…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…
U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent…
DUBLIN–(BUSINESS WIRE)–The “Cryptosporidiosis Global Clinical Trials Review, H1, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. Cryptosporidiosis Global Clinical…
Third party research conducted by leading U.S. institutions to be published in a peer reviewed journal Crohn’s & Colitis 360…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Osteoarthritis” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Osteoarthritis market,…